Press releases

Read more:

Search
Categories

2020

Nanologica AB has within the project with Vicore Pharma been assigned to commence preparative work for the manufacturing of GMP classified material. The...
Nanologica AB has engaged Per Möller, a distinguished scientist with industrial experience, for the purpose of having a qualified advisor for strategic...
Nanologica AB has signed a distribution agreement with American International Chemical LLC (AIC) for the American, Canadian and European market to further...

2019

2019-12-09 15:20 Renewed agreement with crop protection company Regulatory MAR
Nanologica has renewed the agreement with the crop protection company that during the year has performed field studies based on Nanologica’s formulation...
On Dec 5-6, Nanologica will take part in the inaugural Respiratory Drug Delivery conference in London, UK. The purpose of the conference is to bring together...
Diabetes is a disease affecting more than 400 million people worldwide, a number that is expected to increase to more than 640 million by 2040. In 2015...
Nanologica’s drug delivery platform NLAB Silica™ consists of nanoporous amorphous proprietary silica particles. By loading the API in NLAB...
Dr Valetti conducted her research on mesoporous silica particles at Nanologica AB during 2014-2016, as recipient of the prestigious Marie Curie Post Doc...
2019-10-17 07:51 Nanologica’s collaboration project prolonged Regulatory MAR
The agreement between Nanologica and AstraZeneca for the evaluation of Nanologica’s pending patented technology applied to AstraZeneca materials...
English translation NIC-001 is Nanologica’s sublingual formulation of metoclopramide for treating gastroparesis patients. The process for preparing...